Skip to main content
. 2015 May 11;10(5):e0126591. doi: 10.1371/journal.pone.0126591

Table 1. Baseline characteristics and final diagnoses of 835 subjects.

Characteristic n (%)
Female 446 (53.4)
Male 389 (46.6)
Age
< 25 years 111 (13.3)
25–34 years 369 (44.2)
35–44 years 251 (30.1)
≥ 45 years 104 (12.5)
New HIV diagnosis 256 (30.7)
Fever, chills, or night sweats 736 (88.1)
Weight loss (subjective) 797 (95.5)
Cough* 835 (100.0)
Sputum production 766 (91.7)
Dyspnea 436 (52.2)
Wheezing 201 (24.1)
Chest pain 539 (64.6)
Smoked > 99 cigarettes in lifetime 191 (22.9)
Ever consumed alcohol 544 (65.2)
ART ≥ 30 days prior to enrollment 114 (13.7)
PCP prophylaxis ≥ 30 days prior to enrollment 369 (44.2)
Temperature <35.5°C or >38°C 326 (39.0)
Heart rate >120 beats/minute 232 (27.8)
Respiratory rate >30 breaths/minute 378 (45.3)
Oxygen Saturation <90% 137 (16.4)
Abnormal lung exam** 521 (62.4)
CD4 cell count <50 cells/mm3 414 (49.6)
Diagnosis ***
Pulmonary tuberculosis 429 (51.3)
Pneumocystis pneumonia 11 (1.3)
Pulmonary Kaposi’s sarcoma 16 (1.9)
Presumed bacterial pneumonia 80 (9.6)
Other 27 (3.2)
Unknown 277 (33.2)

* Cough was a criterion for study inclusion.

** Rhonchi, crepitations, or bronchial breath sounds.

*** Four subjects had more than one diagnosis: two had pulmonary tuberculosis (TB) & Pneumocystis pneumonia, one had pulmonary TB & pulmonary Kaposi’s sarcoma (KS), one had pulmonary KS & Pneumocystis pneumonia, and one had pulmonary KS and presumed bacterial pneumonia.

ART, antiretroviral therapy; PCP, Pneumocystis pneumonia.